Cryopreserved Platelets in a Non-Toxic DMSO-Free Solution Maintain Hemostatic Function In Vitro.

Int J Mol Sci

Department of Clinical Immunology and Transfusion Medicine (KITM), Karolinska University Hospital, 141 86 Stockholm, Sweden.

Published: August 2023

Dimethyl sulfoxide (DMSO) is regularly used as a cryoprotectant agent for the cryopreservation of platelets. However, DMSO is considered toxic. We therefore hypothesized that saline could be used as a non-toxic medium for the cryopreservation of platelets. Double-dose buffy coat platelets ( = 10) were divided and cryopreserved at -80 °C using 5-6% dimethyl sulfoxide (DMSO) or in NaCl (9 mg/mL). Paired testing was conducted pre-freeze, post-thaw (PT 1 h). Upon analysis, each bag was thawed and reconstituted in fresh plasma. Analyses included cell counts and the metabolic, phenotypic, and functional properties of the platelets together with thromboelastometry. The cryopreserved platelets showed several biochemical and ultrastructural changes compared to pre-freezing. Platelet recovery was approximately 17% higher in DMSO-free units ( < 0.001), but the platelet viability was reduced ( < 0.001). However, using controlled freezing ( = 6), the platelet viability was improved. The clot formation time (CFT) was comparable, but DMSO-free platelets showed slightly decreased maximum clot firmness (MCF) ( = 0.034). By reducing the reconstituted plasma volume, a reduced CFT and increased MCF were obtained ( < 0.001). This study demonstrates that platelets can be cryopreserved in saline without the addition of DMSO, with high recovery and maintained hemostatic function. However, controlled freezing is required to optimize platelet quality.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488190PMC
http://dx.doi.org/10.3390/ijms241713097DOI Listing

Publication Analysis

Top Keywords

cryopreserved platelets
8
hemostatic function
8
dimethyl sulfoxide
8
sulfoxide dmso
8
cryopreservation platelets
8
platelet viability
8
controlled freezing
8
platelets
7
cryopreserved
4
platelets non-toxic
4

Similar Publications

Ovarian tissue cryopreservation for a girl with combined severe hemolytic anemia due to pyruvate kinase deficiency: a case report and literature review.

Gynecol Endocrinol

December 2024

Department of Gynecological Endocrinology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, China.

Objective: To present a young girl with pyruvate kinase deficiency (PKD) and concurrent severe hemolytic anemia who underwent fertility preservation and cryopreservation. Clinical symptoms, diagnosis, treatment, and new strategies for fertility protection and preservation in PKD patients who require allogeneic hematopoietic stem cell therapy are explored.

Case Presentation: Six-year-old girl with persistent unconjugated hyperbilirubinemia and severe hemolytic anemia since birth, continuous elevation of bilirubin levels and severe splenomegaly.

View Article and Find Full Text PDF

Background: Several adult studies show mixed reports in clinical outcomes between cryopreserved and fresh stem cell products, with majority reporting no significant differences and others report that there are differences in outcomes. There is limited literature reporting its impact on outcomes in pediatric hematopoietic cell transplantation (HSCT).

Objective: To compare clinical outcomes between fresh vs cryopreserved stem cell treatment in pediatric HSCT.

View Article and Find Full Text PDF

The biological products used in orthopedics include musculoskeletal allografts-such as bones, tendons, ligaments, and cartilage-as well as biological therapies. Musculoskeletal allografts support the body's healing process by utilizing preserved and sterilized donor tissue. These allografts are becoming increasingly common in surgical practice, allowing patients to avoid more invasive procedures and the risks associated with donor site morbidity.

View Article and Find Full Text PDF
Article Synopsis
  • - The study examines the impact of platelet-rich plasma (PRP) on uterine inflammation and pregnancy rates in jennies (female donkeys) inseminated with frozen donkey semen, which generally shows lower success in jennies compared to mares.
  • - Three groups of jennies were tested: a control group with no treatment, a group receiving a single PRP infusion, and a group getting double PRP infusions around ovulation and artificial insemination (AI).
  • - Results indicated that while S-PRP reduced intrauterine fluid (IUF) accumulation shortly after AI, no significant differences were observed in pregnancy rates among groups, suggesting PRP treatments did not effectively improve outcomes for jennies
View Article and Find Full Text PDF
Article Synopsis
  • Cord blood platelets, collected from non-suitable blood units for stem cell use, are rich in growth factors and may streamline the production of platelet lysate for wound healing applications.
  • The study analyzed the effects of pooled pathogen-reduced lyophilized cord blood platelet lysate (PRL-CBPL) and compared it with single donor cord blood platelet lysate (SD-CBPL) on various cell types essential for wound healing.
  • Results indicated that PRL-CBPL was effective for cell growth with optimal concentrations varying by cell type, while heparin enhanced the effects mainly in SD-CBPL, and both lysates increased monocyte migration in a dose-dependent manner.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!